Company intelligence / Profile preview

Cogniss

Darlinghurst, New South Wales, Australiacogniss.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cogniss provides a no-code platform enabling rapid development of sophisticated digital health applications by healthcare experts and organizations. The platform incorporates validated behavioral science techniques, UX design principles, and artificial intelligence to support the creation of patient-facing apps without coding expertise. It has been used to build research tools, real-world evidence solutions, and digital therapeutics across multiple sectors. No clinical trial results are reported as it does not develop its own therapeutic products.

Therapeutic areas: Other
Modalities: Non-pharmacological therapyDigital therapeuticsDevice (digital app/software)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Blackfinch Ventures (investor/partner)

Beyond the preview

Go deeper on Cogniss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cogniss.

Explore the full profile